Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection?
Journal of the American Board of Family Medicine, 11/09/09
Ong HT – This objective review shows that the rennin–angiotensin antagonists do not have special cardiovascular protective properties.
Related Articles
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease
Annals of Internal Medicine, 10/20/09
Relevance Score: 99%
Adenine/cytosine1166 polymorphism of the angiotensin II type 1 receptor gene and the antihypertensive response to angiotensin-converting enzyme inhibitors
Journal of Hypertension, 10/26/09
Relevance Score: 98%
Angiotensin-converting enzyme and angiotensin II receptor subtype 2 genotypes in type 1 diabetes and severe hypoglycaemia requiring emergency treatment: a case cohort study
Pharmacogenetics and genomics, 10/26/09
Relevance Score: 97%
Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice
Vascular Health and Risk Management, 11/13/09
Relevance Score: 96%
Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care
Clinical Drug Investigation, 11/12/09
Relevance Score: 96%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Transesophageal echocardiography in acute stroke patients with sinus rhythm and no cardiac disease history
Journal of Neurology, Neurosurgery, and Psychiatry , 12/09/09
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
New England Journal of Medicine, 12/09/09
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Canadian Medical Association Journal, 12/09/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner - meta-analysis of six randomized trials
Colorectal Disease, 12/09/09
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
New England Journal of Medicine, 12/09/09
Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma
Liver International, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


